Rankings
▼
Calendar
RNA Q4 2025 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
RNA
Avidity Biosciences, Inc.
$2B
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$860,000
-71.1% YoY
Gross Profit
-$636,000
-74.0% margin
Operating Income
-$254M
-29590.5% margin
Net Income
-$237M
-27569.9% margin
EPS (Diluted)
$-1.59
QoQ Revenue Growth
-93.1%
Cash Flow
Operating Cash Flow
-$170M
Free Cash Flow
-$175M
Stock-Based Comp.
$43M
Balance Sheet
Total Assets
$2.0B
Total Liabilities
$269M
Stockholders' Equity
$1.7B
Cash & Equivalents
$383M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$860,000
$3M
-71.1%
Gross Profit
-$636,000
$3M
-121.4%
Operating Income
-$254M
-$121M
-110.3%
Net Income
-$237M
-$102M
-131.9%
Revenue Segments
Reportable Segment
$860,000
100%
← FY 2025
All Quarters